CA
NZ
UK
AU
IND
US
Director Gregg C. Sengstack of Franklin Electric Co Inc (NASDAQ:FELE) filed a Form 4 on November 3, 2026, disclosing transactions in common stock dated October 30 and November 1, 2026.
Alumni Capital LP, Alumni Capital GP LLC, and Ashkan Mapar jointly filed a Schedule 13G with the SEC on November 3, 2026, disclosing beneficial ownership of 462,916 shares of common stock in Sports Entertainment Gaming Global Corp, representing 9.99% of the class.
Sachem Head Capital Management LP filed a Form 144 notice on November 3, 2026, disclosing a proposed sale of 1,500,000 shares of Performance Food Group Co common stock through broker Jones Trading Institutional Services, LLC on the New York Stock Exchange.
Tomas Navratil, Chief Development Officer of Glaukos Corp, filed a Form 4 on November 3, 2026, disclosing two tax-withholding transactions in common stock that occurred on April 9, 2024.
Replimune Group, Inc. director Kapil Dhingra filed a Form 4 on November 3, 2026, disclosing transactions on November 2, 2026, involving the exercise of a non-qualified stock option and the sale of common stock on NASDAQ:REPL.
Western States Regional Joint Board, Workers United, filed a Form 4 with the SEC on November 3, 2026, disclosing three separate dispositions of Amalgamated Financial Corp. common stock between October 30 and November 3, 2026, on behalf of a group of affiliated labor union …
Workers United and affiliated entities filed a Form 4 with the SEC on November 3, 2026, disclosing three separate sales of Amalgamated Financial Corp. common stock between October 30 and November 3, 2026.
indie Semiconductor, Inc. Chief Financial Officer Wu Naixi filed a Form 4 on November 3, 2026, disclosing the vesting of restricted stock units and a subsequent open-market sale of Class A Common Stock on November 1 and 2, 2026, pursuant to a Rule 10b5-1 …
Bio-Techne Corporation filed an 8-K press release on November 3, 2026, announcing a quarterly cash dividend of $0.08 per share for the quarter ended September 30, 2026, subject to a condition tied to its pending transaction with Merck KGaA, Darmstadt, Germany.
Director Dylan G. Haggart, filing jointly with Fivespan Partners, LP and Fivespan Partners GP, LLC, reported seven open-market purchases of Stride, Inc. common stock between October 30 and November 3, 2026, totaling 228,057 shares acquired indirectly through the Fivespan investment management structure.
Please wait processing your request...